Canadian pharmaceutical industry alarmed after Trump threatens 200% tariff on drug imports
Article content
'Canada is not the target but we could get caught in the crossfire if there are broad-based tariffs on pharmaceuticals,' said Canadian Generic Pharmaceutical Association president Jim Keon.
Article content
Article content
On Tuesday, Trump floated the idea of massive pharmaceutical tariffs but said he would give drug makers up to a year and a half before introducing the duties.
Article content
Article content
Trump launched an investigation under Section 232 of the Trade Expansion Act of 1962 into pharmaceuticals in April, claiming national security concerns linked to America's reliance on imported drugs. A lot of those imported drugs come from China and India.
Article content
A report on that investigation has not been released but Commerce Secretary Howard Lutnick told CNBC Tuesday that details about pharmaceutical duties would come out at the end of the month.
Article content
Generic medicines are used to fill about 90 per cent of all prescriptions in the United States. Canadian exports amount to less than five per cent of all generic medicines sold in the U.S., Keon said.
Article content
Such a low volume shouldn't trigger any U.S. concerns about an overreliance on imports, Keon said.
Article content
He said there is hope that the economic and security agreement being negotiated between Canada and the United States will ensure pharmaceuticals remain tariff-free. Ottawa and the Trump administration have set a July 21 target to finalize the deal.
Article content
Article content
'We have learned over the last six to eight months not to overreact to the statements and wait and see what actually comes out in the executive order in the tariffs themselves,' Keon said.
Article content
Article content
But if Canada is not spared from the looming pharmaceutical duties, Keon said, that would have impacts for Canadian and foreign companies that manufacture drugs in this country.
Article content
Generic pharmaceuticals have a low profit margin. Without access to the American market, Keon said, it might not be practical for some companies in Canada to continue producing certain generic medicines for the domestic market.
Article content
'I think as a Canadian industry and as part of a global industry, we've been operating without tariffs for the last several decades and imposing tariffs is going to increase costs and complicate supply chains,' Keon said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
31 minutes ago
- Globe and Mail
Exact Sciences Schedules Second Quarter 2025 Earnings Call
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its second quarter 2025 financial results after the close of the U.S. financial markets on August 6, 2025. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress. Second quarter 2025 webcast & conference call details A replay of the webcast will be available at The webcast, conference call, and replay are open to all interested parties. About Exact Sciences Corp. A leading provider of cancer screening and diagnostic tests, Exact Sciences helps patients and health care providers make timely, informed decisions before, during, and after a cancer diagnosis. The company's growing portfolio includes well-established brands such as Cologuard ® and Oncotype DX ®, along with innovative solutions like Oncodetect™ for molecular residual disease and recurrence monitoring. Exact Sciences continues to invest in a robust pipeline of advanced cancer diagnostics aimed at improving outcomes. For more information, visit follow @ExactSciences on X, or connect on LinkedIn and Facebook.
Globe and Mail
32 minutes ago
- Globe and Mail
World shares are mixed as investors focus on tariffs and earnings
BANGKOK (AP) — World shares were mixed on Monday as investors focused on tariffs and corporate earnings updates. An announcement over the weekend by U.S. President Donald Trump that he plans 30% tariffs on goods from Mexico and the European Union had a modest immediate impact, as analysts said they expected progress toward trade deals before an Aug. 1 deadline. Trump detailed the planned tariffs Saturday in letters posted to his social media account. The Mexican peso weakened slightly against the dollar, trading at 18.6 pesos to the dollar. Chinese shares advanced after the government reported that exports rose last month as a truce in a tariffs war prompted a surge in orders ahead of an Aug. 12 deadline for reaching a new trade deal with Washington. Hong Kong's Hang Seng gained 0.3% to 24,091.45, while the Shanghai Composite index also was up 0.3%, at 3,519.65. Tokyo's Nikkei 225 index slipped 0.3% to 39,459.62, while the Kospi in South Korea jumped 0.8% to 3,202.03. In Australia, the S&P/ASX 200 edged 0.1% lower to 8,570.40. Taiwan's benchmark lost 0.6%. On Friday, a modest pullback for U.S. stocks left major stock indexes on Wall Street in the red for the week. The S&P 500 closed 0.3% lower, at 6,259.75, a day after setting a record high. The Dow Jones Industrial Average dropped 0.6% to 44,371.51, and the Nasdaq composite gave up 0.2% to 20,585.53 after drifting between small gains and losses much of the day. The tech-heavy index was coming off its own all-time high on Thursday. The selling capped an uneven week in the market as Wall Street kept an eye on the Trump administration's rollout of new tariff threats against trading partners like Canada and looked ahead to the upcoming corporate earnings reporting season. Trump said in a letter Thursday that he will raise taxes on many imported goods from Canada to 35%, deepening the rift between the longtime North American allies. The letter to Canadian Prime Minister Mark Carney was an aggressive increase to the top 25% tariff rates that Trump first imposed in March. The administration had initially set Wednesday as a deadline for countries to make deals with the U.S. or face heavy increases in tariffs. But with just two trade deals announced since April, one with the United Kingdom and one with Vietnam, the window for negotiations has been been extended to Aug. 1. Trump also floated this week that he would impose tariffs of as much as 200% on pharmaceutical drugs and place a 50% tariff on copper imports, matching the rates charged on steel and aluminum. The initial rollout of Trump's tariff policies in the spring roiled financial markets. But they have been relatively stable in recent weeks, suggesting investors have adjusted to the unpredictability of his sudden policy shifts. Markets are set to shift their focus to quarterly earnings over the next few weeks. JPMorgan Chase, Wells Fargo and Citigroup are among big banks due to report their results on Tuesday. Shares in aviation company Red Cat Holdings jumped 26.4% Friday after Defense Secretary Pete Hegseth issued orders aimed at ramping up production and deployment of drones. Bitcoin climbed to another all-time high, rising 3.6% early Monday to $121,914, according to CoinDesk. Bitcoin's price has jumped amid bullish momentum across risk assets and coincides with Nvidia's surge to a $4 trillion valuation. The U.S. Congress' Crypto Week starts Monday. Lawmakers will debate a series of bills that could define the regulatory framework for the industry. In other dealings early Monday, U.S. benchmark crude oil gained 45 cents to $68.90 per barrel. Brent crude, the international standard, was up 44 cents at $70.80 per barrel. The dollar slipped to 147.22 Japanese yen from 147.38 yen. The euro fell to $1.1685 from $1.1692.
CTV News
32 minutes ago
- CTV News
Work-from-home starting to look more remote as companies get stricter on office time
TORONTO — It's not just students who will be commuting more this September. After years of experimentation with hybrid work, an increasing number of companies are whittling down days at home to one, or none at all. The push comes amid rising economic uncertainty that's leaving workers with less leverage and companies under pressure to boost productivity. Even as some experts point to a lack of evidence that more days in the office is good for business, corporate leaders are increasingly convinced it is. 'There are lots of clients who are slowly but surely increasing the in-office requirement,' said Alex Gallacher, managing director of Engage HR. Big banks including RBC, Scotiabank and BMO have mandated at least four days in office starting in September, while Canaccord Genuity is reportedly moving to five, mirroring moves earlier this year by U.S. giants Amazon and JPMorgan to also go all-in on the office. More moves are likely on the way, with 83 per cent of Canadian CEOs saying they expect to move back to full-time in the office within three years, according to a 2024 KPMG survey, a big jump from the 55 per cent who thought so in 2023. Companies have been citing all sorts of benefits to being in the office such as easier collaboration and teamwork, mentorship opportunities and better communication, while Gallacher sees it especially driven by companies trying to get workers on the same page. 'What's really driving it is culture,' said Gallacher. 'This desire to have a culture that is more cohesive, and that effectively supports what the business is trying to do strategically.' For customer-oriented services like banks, working together in person can help emphasize the people-oriented business they're trying to achieve, he said. Banks have said the same themselves, with RBC noting it was moving to more days in-office because it's a 'relationship-driven bank' whose in-person, human connection is core to its culture. Scotiabank noted the collaboration, engagement and career development benefits, as well as a stronger culture and sense of belonging as part of its reasoning. But companywide policies are a fairly blunt way to try and achieve results when location policies actually demand more nuance and specificity, said Linda Duxbury, chancellor's professor of management at Carleton University's Sprott School of Business. 'The decision makers are just making decisions, like the banks, everybody comes back, or the Government of Canada, three days ... it seems like very arbitrary decisions as opposed to doing the hard work necessary.' While companies aim to boost results, it's quite difficult to measure productivity or how well a return-to-office mandate, or home time, is working, said Duxbury. 'They don't have good performance metrics to measure the productivity of a lot of their knowledge workers,' she said. 'So to make the business case why this person can work from home and this one not, it takes a lot of work.' Some researchers have aimed to quantify the effects, such as a research paper out last year from Stanford University economist Nicholas Bloom that studied 1,600 workers at Chinese travel company It found employees who worked two days a week at home were just as productive and likely to be promoted as their fully office-based peers, while turnover among them fell by a third. But even as some data supports hybrid work, companies are making the move because they're convinced the experiment isn't working, said Duxbury. 'They're not just on a whim going, well, hey, I'm going to really make everybody who works for me mad by making people come back in for five days. There's something triggering it.' A sense of culture, of the spirit holding a firm together, has come up a lot in her research, though it can also come down to managers not being able to get in contact with employees too many times, she said. JPMorgan CEO Jamie Dimon didn't hold back when pointing to unreliable employees as one reason the firm moved back to fully in-office. He complained in a February town hall that he could never get ahold of anyone on Fridays, in a recording that was posted by Barron's. He also invited those who didn't like the policy to quit, underlining how retention is becoming less a concern than it was during the peak labour-shortage years of the pandemic. But while it might require broad policies to manage the more than 300,000 employees at JPMorgan, smaller firms seem to be finding it easier to navigate. The KPMG survey, for example, found that only 20 per cent of leaders of small- and medium-sized firms expect to go in-office full time. A big contributor to that trend is also the fight to find and keep talented staff, said Gallacher, noting the push toward more days in office isn't happening as much outside big cities, especially for firms needing more specialized positions. 'If you were to try and go hire a claims manager in the insurance world in southwestern Ontario right now, it is literally like pulling teeth.' But as trends shift and employee leverage fades, Gallacher said it's important to get clarity from any potential employer about what their plans are in terms of office work. 'It's probably as important as salary as a question in terms of, you know, can you manage your life.' This report by The Canadian Press was first published July 14, 2025. Companies in this story: (TSX:RY; TSX;BNS; TSX:BMO) Ian Bickis, The Canadian Press
